Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Zürcher Kantonal Bank

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 169
Average round size
info
The average size of a deal this fund participated in
$7M
Portfolio companies 119
Rounds per year 1.10
Lead investments 17
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.30
Exits 2
Key employees 1

Areas of investment

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Software
Summary

Zu00fcrcher Kantonal Bank appeared to be the Corporate Investor, which was created in 1870. The leading representative office of defined Corporate Investor is situated in the Zu00fcrich. The company was established in Europe in Switzerland.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Zu00fcrcher Kantonal Bank, startups are often financed by investiere | Verve Capital Partners, Foundation for Technological Innovation (FIT), Business Angels Switzerland (BAS). The meaningful sponsors for the fund in investment in the same round are StartAngels Network, 3wVentures, Redalpine Venture Partners. In the next rounds fund is usually obtained by investiere | Verve Capital Partners, Zu00fcrcher Kantonalbank ZKB, OCCIDENT.

The common things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2018. Considering the real fund results, this Corporate Investor is 1 percentage points less often commits exit comparing to other organizations. When the investment is from Zu00fcrcher Kantonal Bank the average startup value is 5-10 millions dollars. The fund is constantly included in 2-6 investment rounds annually.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight GetYourGuide, MerLion Pharma, Stokes Bio. Among the most successful fund investment fields, there are Medical, Information Technology.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Zürcher Kantonal Bank:
Typical Co-investors
Zürcher Kantonal Bank is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Zürcher Kantonal Bank:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Retinai

Artificial Intelligence
Cloud Computing
Health Care
Health Diagnostics
Information Technology
Machine Learning
Software
16 Oct 2024 Bern, Bern, Switzerland

Lymphatica Medtech

Biotechnology
Health Care
Medical
Medical Device
08 Oct 2024 Vaud, Switzerland

Calingo

Financial Services
Insurance
Risk Management
$3M07 Aug 2024 -

ENANTIOS

Biotechnology
Chemical
Pharmaceutical
$1M27 Jun 2024 -

Microcaps

Biotechnology
Computer
Information Technology
Medical
$10M05 Jun 2024 Zurich, Zurich, Switzerland

DataHow

28 May 2024 Zurich, Zurich, Switzerland

Testmate Health

Biotechnology
Health Care
Health Diagnostics
Life Science
Personal Health
Pharmaceutical
$6M02 May 2024 Vaud, Switzerland

Bcomp

Automotive
Manufacturing
Sports
$39M16 Apr 2024 Fribourg, Switzerland

hemotune

Biotechnology
Health Care
Life Science
Medical Device
Therapeutics
$15M25 Mar 2024 Zurich, Zurich, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Zürcher Kantonal Bank?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 169
Average round size 7M
Rounds per year 1.10
Peak activity year 2020
Lead investments 17
Follow on index 0.30
Exits 2
Group Appearance index 0.88

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Retinai

Artificial Intelligence
Cloud Computing
Health Care
Health Diagnostics
Information Technology
Machine Learning
Software
16 Oct 2024 Bern, Bern, Switzerland

Lymphatica Medtech

Biotechnology
Health Care
Medical
Medical Device
08 Oct 2024 Vaud, Switzerland

Calingo

Financial Services
Insurance
Risk Management
$3M07 Aug 2024 -

ENANTIOS

Biotechnology
Chemical
Pharmaceutical
$1M27 Jun 2024 -

Microcaps

Biotechnology
Computer
Information Technology
Medical
$10M05 Jun 2024 Zurich, Zurich, Switzerland

DataHow

28 May 2024 Zurich, Zurich, Switzerland

Testmate Health

Biotechnology
Health Care
Health Diagnostics
Life Science
Personal Health
Pharmaceutical
$6M02 May 2024 Vaud, Switzerland

Bcomp

Automotive
Manufacturing
Sports
$39M16 Apr 2024 Fribourg, Switzerland

hemotune

Biotechnology
Health Care
Life Science
Medical Device
Therapeutics
$15M25 Mar 2024 Zurich, Zurich, Switzerland
Crunchbase icon

Content report

The following text will be sent to our editors: